Psyence Biomedical Ltd. (PBM)Healthcare | Biotechnology | Toronto, Canada | NasdaqCM
2.85 USD
-0.12
(-4.040%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 2.87 +0.02 (0.533%) ⇧ (July 13, 2026, 6:58 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:30 a.m. EDT
The stock is currently trading at a fraction of its book value, yet the underlying business is fundamentally broken with negative returns on assets and equity, massive cash burn, and no earnings. While recent headlines suggest a speculative surge driven by psychedelic policy trends and clinical trial updates, the price action reveals a brutal reality: the asset has lost 99.9% of its value over the last three years, with two consecutive years of catastrophic declines. This multi-year structural deterioration indicates that the market has priced out the business entirely, regardless of the current hype cycle. With no dividend to provide income and a balance sheet showing free cash flow outflows, there is no margin of safety here. The recent price bounce appears to be a volatile, high-risk event rather than a reversal of fortunes, leaving the investment case severely compromised for both immediate and long-term horizons. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.476365 |
| MSTL | 0.489606 |
| AutoARIMA | 0.495652 |
| AutoTheta | 0.974736 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 25% |
| H-stat | 11.40 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.220 |
| Excess Kurtosis | -1.03 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 10,870,834 |
| Beta | 1.68 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://psyencebiomed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9858149 |
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite 1300 |
| All Time High | 341,015.62 |
| All Time Low | 1.92 |
| Ask | 3.66 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 30,930 |
| Average Daily Volume3 Month | 2,664,088 |
| Average Volume | 2,664,088 |
| Average Volume10Days | 30,930 |
| Beta | 1.681 |
| Bid | 2.11 |
| Bid Size | 2 |
| Book Value | 7.389 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.85 |
| Current Ratio | 14.619 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.985 |
| Day Low | 2.82 |
| Display Name | Psyence Biomedical |
| Ebitda | -6,232,245 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.55 |
| Enterprise Value | 3,426,071 |
| Eps Trailing Twelve Months | -12.56 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.0596 |
| Fifty Day Average Change | -1.2096 |
| Fifty Day Average Change Percent | -0.2979604 |
| Fifty Two Week Change Percent | -98.58149 |
| Fifty Two Week High | 468.35938 |
| Fifty Two Week High Change | -465.50937 |
| Fifty Two Week High Change Percent | -0.9939149 |
| Fifty Two Week Low | 1.92 |
| Fifty Two Week Low Change | 0.92999995 |
| Fifty Two Week Low Change Percent | 0.48437497 |
| Fifty Two Week Range | 1.92 - 468.35938 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,639,146,600,000 |
| Float Shares | 2,607,742 |
| Free Cashflow | -4,955,898 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0297 |
| Held Percent Institutions | 0.0402 |
| Implied Shares Outstanding | 3,814,328 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Last Fiscal Year End | 1,774,915,200 |
| Last Split Date | 1,769,990,400 |
| Last Split Factor | 16:100 |
| Long Business Summary | Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market Cap | 10,870,834 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -6,936,421 |
| Next Fiscal Year End | 1,806,451,200 |
| Non Diluted Market Cap | 11,214,124 |
| Open | 2.921 |
| Operating Cashflow | -8,143,007 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 416-477-1708 |
| Post Market Change | 0.015200138 |
| Post Market Change Percent | 0.5333382 |
| Post Market Price | 2.8652 |
| Post Market Time | 1,783,983,529 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 2.97 |
| Price Hint | 4 |
| Price To Book | 0.38570848 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.122 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -4.04041 |
| Regular Market Day High | 2.985 |
| Regular Market Day Low | 2.82 |
| Regular Market Day Range | 2.82 - 2.985 |
| Regular Market Open | 2.921 |
| Regular Market Previous Close | 2.97 |
| Regular Market Price | 2.85 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 29,688 |
| Return On Assets | -0.31333 |
| Return On Equity | -0.58619 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,814,328 |
| Shares Percent Shares Out | 0.0094 |
| Shares Short | 36,005 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 25,988 |
| Short Name | Psyence Biomedical Ltd. |
| Short Percent Of Float | 0.0135 |
| Short Ratio | 0.49 |
| Source Interval | 15 |
| State | ON |
| Symbol | PBM |
| Total Cash | 7,444,763 |
| Total Cash Per Share | 1.952 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -12.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 37.4878 |
| Two Hundred Day Average Change | -34.637802 |
| Two Hundred Day Average Change Percent | -0.9239753 |
| Type Disp | Equity |
| Volume | 29,688 |
| Website | https://psyencebiomed.com |
| Zip | M5H 2K1 |